{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:36:26Z","timestamp":1774928186184,"version":"3.50.1"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Indian Veterinary Research Institute"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ejphar.2015.07.043","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T16:12:10Z","timestamp":1437495130000},"page":"571-581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Reducing A\u03b2 load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease"],"prefix":"10.1016","volume":"764","author":[{"given":"Jaspreet","family":"Kalra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aamir","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2015.07.043_bib1","first-page":"146","article-title":"Uber eine eigenartige Erkrankung der Hirnrinde","volume":"64","author":"Alzheimer","year":"1907","journal-title":"Allg. Z. Psychiatr."},{"key":"10.1016\/j.ejphar.2015.07.043_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/153331750602100211","article-title":"Herbal medicine in the treatment of Alzheimer\u2019s disease","volume":"21","author":"Akhondzadeh","year":"2006","journal-title":"Am. J. Alzheimer's Dis. Other Dement."},{"key":"10.1016\/j.ejphar.2015.07.043_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuropharm.2013.07.004","article-title":"Therapeutics of Alzheimer\u2019s disease: past, present and future","volume":"76","author":"Anand","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2015.07.043_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1590\/0004-282X20130231","article-title":"Treadmill training as an augmentation treatment for Alzheimers disease: a pilot randomized controlled study","volume":"72","author":"Arcoverde","year":"2014","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.ejphar.2015.07.043_bib5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1096\/fj.07-9610com","article-title":"Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways","volume":"22","author":"Atamna","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2015.07.043_bib6","doi-asserted-by":"crossref","DOI":"10.6064\/2012\/246210","article-title":"The genetics of Alzheimer's disease","volume":"2012","author":"Barber","year":"2012","journal-title":"Scientifica"},{"key":"10.1016\/j.ejphar.2015.07.043_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cbpa.2008.02.019","article-title":"Metals in Alzheimer's and Parkinson's diseases","volume":"12","author":"Barnaham","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hpothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2015.07.043_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.21623","article-title":"A gamma secretase inhibitor decreases amyloid-beta production in the central nervous system","volume":"66","author":"Bateman","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/embor.2008.222","article-title":"Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease","volume":"10","author":"Belyaev","year":"2009","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ejphar.2015.07.043_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/npp.2012.172","article-title":"Lithium and GSK3-\u03b2 promoter gene variants influence white matter microstructure in bipolar disorder","volume":"38","author":"Benedetti","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2015.07.043_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.neuro.31.060407.125529","article-title":"Active and passive immunotherapy for neurodegenerative disorders","volume":"31","author":"Brody","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2015.07.043_bib200","doi-asserted-by":"crossref","first-page":"13861","DOI":"10.1523\/JNEUROSCI.3059-10.2010","article-title":"Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy","volume":"41","author":"Brunden","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2015.07.043_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.phrs.2010.12.002","article-title":"The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies","volume":"63","author":"Brunden","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2015.07.043_bib14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.neurobiolaging.2004.06.013","article-title":"Age- and region-dependent alterations in Abeta degrading enzymes: implications for Abeta-induced disorders","volume":"26","author":"Caccamo","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejphar.2015.07.043_bib15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/BF03654836","article-title":"The potential protective effect of tramiprosate (homotaurine) against Alzheimer\u2019s disease: a review","volume":"24","author":"Caltagirone","year":"2012","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2015.07.043_bib16","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1096\/fj.05-5530fje","article-title":"Reductions in levels of the Alzheimer\u2019s amyloid beta peptide after oral administration of ginsenosides","volume":"20","author":"Chen","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2015.07.043_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","article-title":"Treatment with a copper-zinc chelator markedly and rapidly inhibits \u03b2 amyloid deposition in Alzheimer\u2019s disease: transgenic mice","author":"Cherny","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2015.07.043_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2896","article-title":"Alzheimer\u2019s disease: strategies for disease modification","volume":"9","author":"Citron","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2015.07.043_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-0-387-46401-5_8","article-title":"Neuroprotective effects of curcumin","volume":"595","author":"Cole","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4161\/auto.19048","article-title":"Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo","volume":"8","author":"Congdon","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2015.07.043_bib21","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1093\/hmg\/ddq160","article-title":"Molecular mechanisms of neurodegeneration in Alzheimer's disease","volume":"19","author":"Crews","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2015.07.043_bib22","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1021\/ar300074t","article-title":"Therapeutic redistribution of metal ions to treat Alzheimer\u2019s disease","volume":"45","author":"Crouch","year":"2012","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejphar.2015.07.043_bib23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1096\/fj.10-167213","article-title":"\u03b2 Secretase inhibitor GRL8234 rescues age related cognitive decline in APP transgenic mice","volume":"25","author":"Chang","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2015.07.043_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.7326\/0003-4819-158-3-201302050-00005","article-title":"The association between midlife cardio respiratory fitness levels and later-life dementia: a cohort study","volume":"158","author":"Defina","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2015.07.043_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1745-7254.2005.00102.x","article-title":"Effects of melatonin on wortmannin-induced tau hyperphosphorylation","volume":"26","author":"Deng","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2015.07.043_bib27","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1038\/tp.2013.59","article-title":"Mechanisms that lessen benefits of \u03b2-secretase reduction in a mouse model of Alzheimer\u2019s disease","volume":"3","author":"Devi","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.07.043_bib28","doi-asserted-by":"crossref","first-page":"8914","DOI":"10.1523\/JNEUROSCI.1178-08.2008","article-title":"Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS","volume":"28","author":"Dill","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2015.07.043_bib29","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn842","article-title":"Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model","volume":"5","author":"Dodart","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2015.07.043_bib30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2010.06.020","article-title":"SIRT1 suppresses beta amyloid production by activating the alpha-secretase gene ADAM10","volume":"142","author":"Donmez","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2015.07.043_bib31","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1471-4159.2006.04139.x","article-title":"Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert","volume":"99","author":"Engel","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2015.07.043_bib32","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jalz.2009.04.1016","article-title":"The role of CSF dynabridging studies in developing new therapies for Alzheimer\u2019s disease","volume":"5","author":"Ereshefsky","year":"2009","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejphar.2015.07.043_bib33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/1533317513488921","article-title":"The effects of sleep quality, physical activity, and environmental quality on the risk of falls in dementia","volume":"28","author":"Eshkoor","year":"2013","journal-title":"Am. J. Alzheimer's Dis. Other Dement."},{"key":"10.1016\/j.ejphar.2015.07.043_bib201","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000122962","article-title":"Treatment options in Alzheimer's disease: maximizing benefit, managing expectations","volume":"5","author":"Farlow","year":"2008","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.ejphar.2015.07.043_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1750-3639.2004.tb00493.x","article-title":"Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer\u2019s disease","volume":"14","author":"Ferrer","year":"2004","journal-title":"Brain Pathol."},{"issue":"5","key":"10.1016\/j.ejphar.2015.07.043_bib35","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/mt.2008.39","article-title":"Reduced pathology and improved behavioral performance in alzheimer\u2019s disease mice vaccinated with HSV amplicons expressing amyloid-\u03b2 and interleukin-4","volume":"16","author":"Frazer","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejphar.2015.07.043_bib36","first-page":"CD007769","article-title":"Ginseng for cognition","volume":"12","author":"Geng","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2015.07.043_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1471-4159.2011.07476.x","article-title":"Developing \u03b2 secretase inhibitors for treatment of Alzheimer's disease","volume":"120","author":"Ghosh","year":"2012","journal-title":"J. Neurochem."},{"issue":"19","key":"10.1016\/j.ejphar.2015.07.043_bib38","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1039\/C3CS60460H","article-title":"BACE1 (\u03b2-secretase) inhibitors for the treatment of Alzheimer\u2019s disease","volume":"43","author":"Ghosh","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejphar.2015.07.043_bib39","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2015.07.043_bib40","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00018-009-0233-x","article-title":"The enhancement of antiproliferative and proapoptotic activity of HDAC inhibitors by curcumin is mediated by Hsp90 inhibition","volume":"67","author":"Giommarelli","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2015.07.043_bib41","first-page":"S3","article-title":"NAP and D-SAL: neuroprotection against the beta amyloid peptide (1\u201342)","volume":"9","author":"Gozes","year":"2008","journal-title":"B.M.C. Neurosci."},{"key":"10.1016\/j.ejphar.2015.07.043_bib42","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2174\/138161211795589373","article-title":"NAP (davunetide) provides functional and structural neuroprotection","volume":"17","author":"Gozes","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2015.07.043_bib43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0278-5846(88)90102-9","article-title":"Glutamate transmission and toicity in Alzheimer\u2019s disease","volume":"12","author":"Greenamyre","year":"1988","journal-title":"Prog. Neuro-Psych. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.07.043_bib44","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1517\/14728222.12.6.693","article-title":"Emerging and potential therapies for Alzheimer\u2019s disease","volume":"12","author":"Griffiths","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2015.07.043_bib202","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2165\/00002512-200623120-00003","article-title":"Effects of cholinesterase inhibitors on behavioural disturbances in Alzheimer's disease: a systematic review","volume":"12","author":"Grimmer","year":"2006","journal-title":"Drugs Aging."},{"key":"10.1016\/j.ejphar.2015.07.043_bib45","first-page":"98","article-title":"Neprilysin and Ab clearance: impact of the APP intracellular domain in NEP regulation and implications in Alzheimer's disease","volume":"23","author":"Grimm","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejphar.2015.07.043_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jalz.2009.04.287","article-title":"NIC5-15 as a treatment for Alzheimer\u2019s: safety, pharmacokinetics and clinical variables","volume":"5","author":"Grossman","year":"2009","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejphar.2015.07.043_bib48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/14737175.2015.995637","article-title":"Advances in the therapy of Alzheimer\u2019s disease: targeting amyloid beta and tau and perspectives for the future","volume":"15","author":"Hampel","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejphar.2015.07.043_bib49","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4088\/JCP.08m04606","article-title":"Lithium trial in Alzheimer\u2019s disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study","volume":"70","author":"Hampel","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.07.043_bib50","unstructured":"Han, M. et al., 2010. Preparation of small molecule compounds for promoting stem cells hyperplasia. P.C.T Int. Appl. 41 pp. WO 2010130063, A1 20101118, CAN 153:643462"},{"key":"10.1016\/j.ejphar.2015.07.043_bib51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JAD-2004-6504","article-title":"Development of a safe oral A\u03b2 vaccine using recombinant adeno-associated virus vector for Alzheimer\u2019s disease","volume":"6","author":"Hara","year":"2004","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.ejphar.2015.07.043_bib52","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2015.07.043_bib53","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/1099-1166(200012)15:12<1125::AID-GPS257>3.0.CO;2-F","article-title":"Improvement of agitation and anxiety in demented patients after psychoeducative group intervention with their caregivers","author":"Haupt","year":"2000","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.07.043_bib54","first-page":"548","article-title":"Small molecule inhibitors of A beta-aggregation and neurotoxicity. Drug Dev. Res. 70, 111\u2013124.icro-PET imaging","volume":"29","author":"Hawkes","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2015.07.043_bib55","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1517\/14656560903044982","article-title":"Development of semagacestat (LY450139), a functional gamma-secretase inhibitor, for the treatment of Alzheimer\u2019s disease","volume":"10","author":"Henley","year":"2009","journal-title":"Exp. Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2015.07.043_bib57","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.apmr.2004.03.019","article-title":"The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis","volume":"85","author":"Heyn","year":"2004","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.ejphar.2015.07.043_bib58","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunisation in Alzheimer\u2019s disease: follow-up of a randomised, placebo controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2015.07.043_bib59","doi-asserted-by":"crossref","first-page":"77sr1","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer\u2019s disease: the challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2015.07.043_bib60","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1021\/cn3000179","article-title":"Molecule spotlight on BMS-708163","volume":"5","author":"Hopkins","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2015.07.043_bib61","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nbd.2008.10.007","article-title":"GSK3 inhibitors show benefits in an Alzheimer\u2019s disease (AD) model of neurodegeneration but adverse effects in control animals","volume":"33","author":"Hu","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2015.07.043_bib62","unstructured":"Humanetics Pharmaceuticals, 2009. A disease modifying drug candidate for Alzheimer\u2019s disease. NIC515. Available at: \u3008http:\/\/www.humaneticscorp.com\/ittrium\/visit?\u3009 (accessed 08.07.09)."},{"key":"10.1016\/j.ejphar.2015.07.043_bib63","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3233\/JAD-2012-120439","article-title":"Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer\u2019s disease-related neuropathies: involvement of non-amyloidogenic processing","volume":"31","author":"Hwang","year":"2012","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.ejphar.2015.07.043_bib64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/JAD-2010-1366","article-title":"CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease","volume":"20","author":"Imbimbo","year":"2010","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.ejphar.2015.07.043_bib65","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1073\/pnas.0710823105","article-title":"Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade","volume":"105","author":"Jacobsen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2015.07.043_bib66","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jalz.2009.05.472","article-title":"GSI-953 is a potent APP-selective gamma-secretase inhibitor for the treatment of Alzheimer's disease","volume":"5","author":"Jacobsen","year":"2009","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejphar.2015.07.043_bib67","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/anie.200802808","article-title":"Alzheimer\u2019s disease: from pathology to therapeutic approaches","volume":"48","author":"Jakob-Roetne","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejphar.2015.07.043_bib68","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/156720510791162377","article-title":"Colostral proline-rich polypeptides--immunoregulatory properties and prospects of therapeutic use in Alzheimer\u2019s disease","volume":"7","author":"Janusz","year":"2010","journal-title":"Curr. Alzheimer. Res."},{"key":"10.1016\/j.ejphar.2015.07.043_bib69","doi-asserted-by":"crossref","DOI":"10.1177\/1470320315583582","article-title":"Cerebroprotective effects of RAS inhibitors: beyond their cardio-renal actions","author":"Kalra","year":"2015","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.ejphar.2015.07.043_bib70","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/j.1476-5381.2011.01221.x","article-title":"Alzheimer\u2019s disease and metals: therapeutic opportunities","volume":"163","author":"Kenche","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib71","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5142\/jgr.2013.37.54","article-title":"Ginsenoside Rd inhibits the expressions of iNOS and COX-2 by suppressing NF-\u03baB in LPS-stimulated RAW264.7 cells and mouse liver","volume":"37","author":"Kim","year":"2013","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.ejphar.2015.07.043_bib72","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.bjp.0706122","article-title":"Neuritic regeneration and synaptic reconstruction induced by withanolides. A","volume":"144","author":"Kuboyama","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib73","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuro.2014.02.004","article-title":"Oxidative stress and mitochondrial dysfunction in aluminium neurotoxicity and its amelioration: a review","volume":"41","author":"Kumar","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejphar.2015.07.043_bib74","doi-asserted-by":"crossref","first-page":"77624","DOI":"10.1371\/journal.pone.0077624","article-title":"Ashwagandha (Withania somnifera) reverses \u03b2-Amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-Associated Neurocognitive Disorders (HAND)","volume":"8","author":"Kurapati","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2015.07.043_bib75","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.pnpbp.2010.07.018","article-title":"Novel insights for the treatment of Alzheimer's disease","volume":"35","author":"Kurz","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.07.043_bib76","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nurt.2008.05.003","article-title":"PPAR gamma agonists as therapeutics for the treatment of Alzheimer\u2019s disease","volume":"5","author":"Landreth","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejphar.2015.07.043_bib77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000048668","article-title":"Influence of the severity of cognitive Impairment on the effect of the Ginkgo biloba extract EGb 761in Alzheimer\u2019s disease","volume":"45","author":"Le Bars","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.ejphar.2015.07.043_bib78","doi-asserted-by":"crossref","first-page":"12920","DOI":"10.1074\/jbc.M112.424820","article-title":"Transcriptional regulation of insulin-degrading enzyme modulates mitochondrial amyloid \u03b2 (A\u03b2) peptide catabolism and functionality","volume":"288","author":"Leal","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2015.07.043_bib79","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/embo-reports\/kvd107","article-title":"Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer\u2019s disease brains","volume":"1","author":"Ledesma","year":"2000","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ejphar.2015.07.043_bib80","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3233\/JAD-2009-1149","article-title":"Ginseng for cognitive function in Alzheimer\u2019s disease: a systematic review","volume":"18","author":"Lee","year":"2009","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.ejphar.2015.07.043_bib81","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1074\/jbc.M511018200","article-title":"Targeting A\u03b2 oligomers by passive immunization with a conformation selective monoclonal antibody improves learning and memory in APP transgenic mice","volume":"281","author":"Lee","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2015.07.043_bib83","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/WAD.0b013e31816c92e6","article-title":"Panax ginseng enhances cognitive performance in Alzheimer disease","volume":"22","author":"Lee","year":"2008","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.ejphar.2015.07.043_bib84","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/1570159X11311040002","article-title":"Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century","volume":"11","author":"Lee","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib85","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","article-title":"Enhanced proteolysis of A-beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death","volume":"40","author":"Leissring","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2015.07.043_bib87","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1750-1326-8-36","article-title":"Immunotherapy for Alzheimer\u2019s disease: hoops and hurdles","volume":"8","author":"Lemere","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejphar.2015.07.043_bib88","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1172\/JCI25410","article-title":"Anti-A\u03b242- and anti-A\u03b240-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model","volume":"116","author":"Levites","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2015.07.043_bib89","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-079X.1998.tb00530.x","article-title":"N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-kappaB","volume":"24","author":"Lezoualc\u2019h","year":"1998","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ejphar.2015.07.043_bib90","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsb.2005.12.011","article-title":"Metal exposure and Alzheimer Pathogenesis","volume":"155","author":"Liu","year":"2006","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib91","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1249\/MSS.0b013e31822cf717","article-title":"Cardiorespiratory fitness as a predictor of dementia mortality in men and women","volume":"44","author":"Liu","year":"2012","journal-title":"Med. Sci. Sports. Exerc."},{"key":"10.1016\/j.ejphar.2015.07.043_bib92","doi-asserted-by":"crossref","first-page":"9511","DOI":"10.1073\/pnas.0701055104","article-title":"Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies","volume":"104","author":"Luo","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2015.07.043_bib93","doi-asserted-by":"crossref","first-page":"12197","DOI":"10.1073\/pnas.182425199","article-title":"Inhibition of amyloid \u2013beta aggregation and caspase -3 activation by the Ginkgo biloba extract EGb761","volume":"99","author":"Luo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2015.07.043_bib94","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-2008-15207","article-title":"Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG)","volume":"15","author":"Mandel","year":"2008","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.ejphar.2015.07.043_bib96","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JAD-2011-101899","article-title":"Amyloid-beta-induced amyloid-beta secretion: a possible feed-forward mechanism in Alzheimer\u2019s disease","volume":"24","author":"Marsden","year":"2011","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.ejphar.2015.07.043_bib97","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.WNL.0000148590.39911.DF","article-title":"A beta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease","volume":"64","author":"Masliah","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2015.07.043_bib99","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1468-1331.2006.01409.x","article-title":"Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer\u2019s dementia in a randomized placebo-controlled double-blind study","volume":"13","author":"Mazza","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib100","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1074\/jbc.271.3.1343","article-title":"Differential effects of a Rab6 mutant on secretory versus amyloidogenic processing of Alzheimer\u2019s beta-amyloid precursor protein","volume":"271","author":"McConlogue","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2015.07.043_bib101","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2009.01.013","article-title":"Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro","volume":"452","author":"Mei","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2015.07.043_bib102","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1750-3639.2011.00486.x","article-title":"Neprilysin protects against cerebral amyloid angiopathy and A\u03b2-induced degeneration of cerebrovascular smooth muscle cells","volume":"21","author":"Miners","year":"2011","journal-title":"Brain. Pathol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib103","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0972-2327.40220","article-title":"The effect of curcumin (turmeric) on Alzheimer\u2019s disease: an overview","volume":"11","author":"Mishra","year":"2008","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib104","doi-asserted-by":"crossref","first-page":"20372050","DOI":"10.1523\/JNEUROSCI.4264-11.2012","article-title":"Differential Effects between \u03b3 Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein Transgenic and Non transgenic Mice","volume":"32","author":"Mitani","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2015.07.043_bib105","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuroscience.2007.09.063","article-title":"Chronic lithium treatment magnifies learning in rats","volume":"150","author":"Nocjar","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2015.07.043_bib106","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12031-011-9644-x","article-title":"Effect of sodium valproate administration on brain neprilysin expression and memory in rats","volume":"46","author":"Nalivaeva","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2015.07.043_bib107","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1021\/bi700411k","article-title":"Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization","volume":"46","author":"Necula","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2015.07.043_bib108","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report","volume":"9","author":"Nicoll","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2015.07.043_bib109","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00228-012-1459-3","article-title":"Has inhibition of A\u03b2 production adequately been tested as therapeutic approach in mild AD? A model-based meta-analysis of \u03b3-secretase inhibitor data","volume":"69","author":"Niva","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib110","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1073\/pnas.0500466102","article-title":"Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo","volume":"102","author":"Noble","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2015.07.043_bib111","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer's disease","volume":"34","author":"O\u2019Brien","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2015.07.043_bib112","doi-asserted-by":"crossref","first-page":"26832","DOI":"10.1074\/jbc.M702640200","article-title":"Statins reduce amyloid-beta production through inhibition of protein isoprenylation","volume":"282","author":"Ostrowski","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2015.07.043_bib113","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s007020050018","article-title":"An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: Implications for AD","volume":"107","author":"Pappolla.","year":"2000","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.ejphar.2015.07.043_bib114","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/hmg\/dds100","article-title":"Neuropathogenic role of adenylate kinase-1 in A\u03b2-mediated tau phosphorylation via AMPK and GSK3\u03b2","volume":"21","author":"Park","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2015.07.043_bib115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/BJ20060655","article-title":"Statins inhibit the dimerization of betasecretase via both isoprenoid- and cholesterol-mediated mechanisms","volume":"399","author":"Parsons","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2015.07.043_bib116","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbr.2008.03.014","article-title":"The impact of voluntary exercise on mental health in rodents: a neuroplasticity perspective","volume":"192","author":"Pietropaolo","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2015.07.043_bib117","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI20864","article-title":"A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer\u2019s disease mouse model","volume":"113","author":"Postina","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2015.07.043_bib118","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/gps.2641","article-title":"A systematic review of the effects of physical activity on physical functioning, quality of life and depression in older people with dementia","volume":"26","author":"Potter","year":"2011","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.07.043_bib119","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","article-title":"Epidemiology of Alzheimer\u2019s disease: occurrence, determinants, and strategies toward intervention","volume":"11","author":"Qiu","year":"2009","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2015.07.043_bib203","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1371\/journal.pmed.0040338","article-title":"Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials","volume":"11","author":"Raschetti","year":"2007","journal-title":"PLoS. Med."},{"key":"10.1016\/j.ejphar.2015.07.043_bib120","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine Study Group: Memantine in moderate-to-severe Alzheimer\u2019s disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2015.07.043_bib121","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.arcmed.2012.11.008","article-title":"Alzheimer\u2019s disease: critical notes on the history of a medical concept","volume":"43","author":"Ramirez-Bermudez","year":"2012","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ejphar.2015.07.043_bib122","doi-asserted-by":"crossref","first-page":"18177","DOI":"10.1074\/jbc.M709715200","article-title":"Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3- kinase, phospholipase Cgamma1 Grb2, and Src family kinases","volume":"283","author":"Reynolds","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2015.07.043_bib123","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/alzrt146","article-title":"Oral curcumin for Alzheimer\u2019s disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study","volume":"4","author":"Ringman","year":"2012","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.ejphar.2015.07.043_bib124","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3233\/JAD-2010-1262","article-title":"Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer\u2019s disease","volume":"19","author":"Rojo","year":"2010","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.ejphar.2015.07.043_bib125","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/archneur.59.9.1367","article-title":"Explaining the cause of amyloid burden in Alzheimer disease","volume":"59","author":"Rosenberg","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib126","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nm1206","article-title":"Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation","volume":"11","author":"Saito","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2015.07.043_bib127","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/JGP.0b013e3181eb00a9","article-title":"Physical activity and Alzheimer disease course","volume":"19","author":"Scarmeas","year":"2011","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.07.043_bib128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-\u03b2 attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2015.07.043_bib129","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/sj.bjp.0707471","article-title":"Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation","volume":"152","author":"Selenica","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.brainres.2009.01.019","article-title":"SK-PC-B70M confers anti-oxidant activity and reduces A beta levels in the brain of Tg2576 mice","volume":"1261","author":"Seo","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2015.07.043_bib131","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological Alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejphar.2015.07.043_bib132","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9440(10)61715-4","article-title":"Immunization with a nontoxic\/nonfibrillar amyloid-\u03b2 homologous peptide reduces Alzheimer\u2019s disease-associated pathology in transgenic mice","volume":"159","author":"Sigurdsson","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib134","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jalz.2009.04.267","article-title":"A\u03b2 variability and effect of gamma secretase inhibition on cerebrospinal fluid levels of A\u03b2 in healthy volunteers","volume":"5","author":"Soares","year":"2009","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejphar.2015.07.043_bib135","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tins.2008.11.007","article-title":"Tau Pathophysiology in neurodegeneration: a tangled issue","volume":"32","author":"Spires-Jones","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2015.07.043_bib136","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00702-004-0188-x","article-title":"Alzheimer\u2019s associated inflammation, potential drug targets and future therapies","volume":"112","author":"Stuchbury","year":"2005","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.ejphar.2015.07.043_bib137","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neures.2008.06.005","article-title":"Embryonic stem cell-derived neural precursor cells improve memory dysfunction in A beta (1\u201340) injured rats","volume":"62","author":"Tang","year":"2008","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.ejphar.2015.07.043_bib138","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbr.2006.11.003","article-title":"Enhancing effects of chronic lithium on memory in the rat","volume":"177","author":"Tsaltas","year":"2007","journal-title":"Behav. Brain Res."},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2015.07.043_bib139","first-page":"457","article-title":"Lithium and cognitive enhancement: leave it or take it?","volume":"202","author":"Tsaltas","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2015.07.043_bib140","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1007\/s00406-013-0449-5","article-title":"Pathology of clinical and preclinical Alzheimer\u2019s disease","volume":"263","author":"Thal","year":"2013","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2015.07.043_bib141","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/alzrt54","article-title":"Herbal therapy: a new pathway for the treatment of Alzheimer\u2019s disease","volume":"2","author":"Tian","year":"2010","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.ejphar.2015.07.043_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2012.12.026","article-title":"The protective effect of hyperbaric oxygen and Ginkgo biloba extract on A\u03b225-35-induced oxidative stress and neuronal apoptosis in rats","volume":"242","author":"Tian","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2015.07.043_bib143","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1586\/ern.09.24","article-title":"Secretase inhibitors and modulators for Alzheimer's disease treatment","volume":"9","author":"Tomita","year":"2009","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejphar.2015.07.043_bib144","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ana.21051","article-title":"Orally available compound prevents deficits in memory caused by the Alzheimer Amyloid-\u03b2 oligomers","volume":"60","author":"Townsend","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.0962-1105.2003.00374.x","article-title":"The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer\u2019s disease","volume":"12","author":"Tractenberg","year":"2003","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.ejphar.2015.07.043_bib146","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1472-8206.2008.00578.x","article-title":"Current and future therapy in Alzheimer\u2019s disease","volume":"22","author":"Van Marum","year":"2008","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib147","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bcp.2013.12.020","article-title":"Immunotherapy for Alzheimer\u2019s disease","volume":"88","author":"Wisniewski","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.07.043_bib148","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jalz.2008.05.1453","article-title":"Efficacy of the novel \u03b3-secretase inhibitor, PF-3084014, in reducing A\u03b2 in brain, CSF, and plasma in guinea pigs and Tg2576 mice","volume":"4","author":"Wood","year":"2008","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejphar.2015.07.043_bib149","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1210\/jc.2003-030833","article-title":"Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease; alterations in preclinical and clinical stages","volume":"88","author":"Wu","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2015.07.043_bib150","first-page":"528","article-title":"Current advances in the treatment of Alzheimer\u2019s disease: focused on considerations targeting A\u03b2 and tau","volume":"34","author":"Yang","year":"2009","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejphar.2015.07.043_bib151","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bbrc.2014.04.041","article-title":"Potent \u03b3-secretase inhibitors\/modulators interact with amyloid-\u03b2 fibrils but do not inhibit fibrillation: A high-resolution NMR study","volume":"447","author":"Yesuvadian","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2015.07.043_bib153","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1745-7254.2008.00785.x","article-title":"Biological characters of [F-18]O-FEt-PIB in a rat model of Alzheimer\u2019s disease using micro-PET imaging","volume":"29","author":"Zheng","year":"2008","journal-title":"Acta Pharmacol. Sin."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915301710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915301710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:28:58Z","timestamp":1757975338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915301710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":148,"alternative-id":["S0014299915301710"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.07.043","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing A\u03b2 load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.07.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}